This article will look at the top 10 pharma companies in India based on their market capitalization.
India is the second most populous country in the world, housing around 140 crore people. India has a massive pharma industry to take care of these many people. Not just India, the pharma industry of India plays a significant part in the international sector of the pharmaceutical industry. This article will look at the top 10 pharma companies in India based on their market capitalization.
India is ranked third in the world for its output in terms of volume and fourteenth for production in terms of value. The country is the world’s biggest maker of vaccines and generic pharmaceuticals. Its portion in the global supply of generic medications accounts for 20% of the total volume. (1)
In addition, India is home to more than 3,000 pharmaceutical companies, a robust network of over 10,500 production facilities, and a highly qualified talent pool. India also has the biggest number of pharmaceutical plants that comply with US-FDA regulations outside the United States.
India makes more than 500 active pharmaceutical ingredients (APIs) and is the source of 60,000 generic brands. This makes India’s API industry the third largest in the world. Most supplies comprise medicines that can be bought without a prescription and are used to treat common conditions that don’t pose a life-threatening risk.
Mumbai, Bangalore, Hyderabad, Pune, Visakhapatnam, and Ahmedabad are the most important cities for the pharmaceutical industry. India’s major generic drug makers, such as Sun Pharma, Cipla, Dr. Reddy’s Laboratories, Lupin, Aurobindo Pharma, etc., have a large and powerful position in the global drug supply chain.
We will organize the list based on the market cap of the companies, in descending order. We will have a look at each one of them individually.
Sun Pharma is one of the biggest generic pharmaceutical companies in the world. Mr. Dilip Sanghvi founded Sun Pharma in 1983. Sun Pharma has its headquarters in Mumbai. (2) Sun Pharma has a Market Cap of Rs. 2,21,000 Crore and is in the lead position among the top 10 pharma companies in India.
Sun Pharma is among the top ten generic drug manufacturers in the US and second in the number of prescriptions in the generic dermatological industry. It exports drugs to more than 70 countries worldwide and has over 36,000 employees.
With a presence in over 80 markets, Sun Pharma is the largest Indian corporation in emerging markets like South Africa, Brazil, Mexico, Russia, and Romania.
Sun Pharma produces and markets various pharmacological formulations for chronic and urgent treatments. It comprises over-the-counter (OTC) medications, antiretrovirals (ARVs), active pharmaceutical ingredients (APIs), and intermediary formulations.
Sun Pharma sells more than 30 billion doses annually across various medical specialties, including neuro-psychiatry, cardiology, gastroenterology, anti-infectives, diabetology, oncology, ophthalmology, dermatology, urology, nephrology, and respiratory.
Popular brands of Sun Pharma include Abzorb Powders, Volini, Revital, Pepfiz, and Suncross sunscreens.
Dr. Khwaja Abdul Hamied founded CIPLA in 1835. CIPLA is an acronym for Chemical Industrial & Pharmaceutical Laboratories Ltd. It was the first pharmaceutical company in India. (3) It is currently second in market cap amongst pharmaceutical companies in India. CIPLA has its headquarters in Mumbai.
The business is well known for being the top supplier of antiretroviral drugs. The corporation has a presence worldwide and is renowned for producing important pharmaceuticals. Its product range has more than 1500 different items.
CIPLA has a market cap of Rs. 86,000 crores. This cemented its spot in the top 10 pharma companies in India. It exports to more than 60 countries and has more than 30,000 employees.
Cipla has been instrumental in significantly changing the Indian Generic drug market. It was one of the first companies which helped change the Indian Governments outlook towards patents of pharma drugs.
This has enabled CIPLA and other Indian pharma companies to make and distribute cheaper versions of otherwise expensive drugs under patent. This has made such drugs more affordable to more people.
Cipla is especially well known for its Respiratory inhaler range of products for asthma.
Dr. Reddy’s Labs was founded by Kallam Anji Reddy in 1984 and is based in Hyderabad. (4)
It provides various goods and services worldwide, such as API, generic medicines, branded generics, biosimilars, and OTC pharmaceutical items. They cater to various primary therapeutic specialties, including dermatology, oncology, pain management, diabetology, gastroenterology, and diabetology.
The company has a market cap of Rs. 68,700 Crores and is among the top pharma companies in India. It provides healthcare to more than 500 million patients globally through its R&D centers, production sites, and commercial presence worldwide. It hopes to triple its reach by 2030.
Dr. Reddy’s exports drugs to over 66 counties and has over 24,000 employees.
Reddy’s It has garnered much media attention due to its participation in disseminating and assessing the Russian Covid-19 vaccine Sputnik.
Venusia, Glimy, Telsartan, and Reditux are some of the popular brands of Dr. Reddy’s.
Torrent Pharma is one of the top pharma companies in India. Uttambhai Nathalal Mehta founded the company in 1959. The headquarters of the company is in Ahmedabad, Gujarat. The Torrent Group operates the company. (5)
The company was amongst the first to introduce the idea of niche marketing to India, and it is now among the top pharma companies in India in the therapeutic segments of women’s health, cardiovascular, nervous system, and gastrointestinal healthcare. The company also has a significant presence in gynecology, cancer, diabetology, pain treatment, and anti-infective industries.
The world-class production facilities, cutting-edge R & D capabilities, vast domestic network, and substantial international presence in over 40 countries provide Torrent Pharma a competitive advantage.
The market cap of torrent pharma is Rs. 51,300 crores, which means it is fourth in the top 10 pharma companies in India. It has more than 13,000 employees.
Alkem Labs started its operations in 1973, founded by Mr. Samprada Singh. (6) The company has its HQ in Mumbai. The company has a workforce of around 17,000. It is present in more than 50 countries.
The market cap of Alkem labs is around Rs. 39,000. This makes it the fifth in the top 10 pharma companies in India. The company caters to various therapeutic segments, including anti-infective, gastroenterological, analgesic, pain relief, anti-diabetic, cardiology, dermatological, neurologic/central nervous system (CNS), vitamins, minerals, and nutrients.
Famous pharmaceutical brands such as Clavam, Pan, Pan-D, and Taxim-O are represented in Alkem’s portfolio. These brands are ranked among the top 50 pharmaceutical brands in India. Our uncontested leadership in the anti-infective market has been maintained for more than a decade at this point.
Abbott India Ltd (Abbott India), a subsidiary of Abbott Laboratories, is responsible for researching and developing a wide variety of branded generic pharmaceuticals, diagnostic tools, nutritional products, and vascular and diabetes devices. It has been operating in India since 1944 and has been among the top pharma companies in India.
It has its HQ in Mumbai. It has a market cap of Rs. 37,000 crores in the Indian pharmaceutical business sphere. This makes it sixth in the top 10 pharma companies in India.
Abbott India manufactures and markets all of these products. The company’s product line includes multi-specialty medications, vitamins, and a broad range of treatments for hypothyroidism, vertigo, epilepsy, depression, and migraines, among other conditions.
The company provides vaccines to prevent influenza, typhoid fever, and diarrhea. Tablets, injectables, liquids, ointments, granules, powder, and capsules are some of the different forms Abbott India’s pharmaceuticals can take, including granules, powder, and powder.
The product line of Abbott assists in treating gynecological, gastroenterological, urological, and neurological illnesses and pain, infection, and diabetes. The production site for Abbott India is located in Goa, India, and the company’s headquarters may be found in Mumbai, Maharashtra, India.
Some of the trusted brands of Abbott India are Thyronorm, Eptoin, Duphaston, Duphalac, Vertin, Digene, and Prothiaden. (7)
Zydus Lifesciences Ltd is a pharmaceutical manufacturer focusing on specialized and generic medicine production. Ramanbhai Patel founded the company in 1952. The company has its HQ in Ahmedabad and has a market capitalization of Rs. 36,000. Zydus Healthcare is amongst the top pharma companies in India. (8)
Zydus Cadila develops and produces a wide variety of pharmaceuticals, diagnostics, herbal items, skincare products, and other over-the-counter products. The company operates twenty-five pharmaceutical production facilities throughout India.
The company began manufacturing generic medications for hepatitis C at the end of 2015 after completing negotiations with Gilead on a voluntary license agreement.
Among its many product names, a few popular ones are Aten, Falcigo, Nucoxia, Levoday, Metscore, and Arzep.
Gland Pharma was founded in 1978 in Hyderabad, India, and has since developed into one of the biggest and fastest-growing generic injectables manufacturing companies. PVN Raju founded the company in 1978. It is the eighth among the top pharma companies in India, with a market cap of Rs. 35,000 crores.
The company has a global footprint in more than 60 countries, including the United States, Europe, Canada, Australia, and India, as well as other markets, and began as a contract manufacturer of small volume liquid parenteral products.
It is largely a B2B player globally but also has a footprint in the prescription market in India. (9) The main therapy areas it caters to are Anti-infectives, anti-malarial, cardiology, orthopedics, gastro, Hormone & Related Drugs, and many others.
The company has a total of four manufacturing facilities located in Hyderabad and Visakhapatnam.
From 1988–1989, the business began its activities in Puducherry by establishing a single facility for producing semi-synthetic penicillin (SSP). In 1992, Aurobindo Pharma went public, and the following year, in 1995, the company began trading its shares on the stock markets in India.
It was founded by V. Ramprasad Reddy and K. Nityananda Reddy. Presently, the company has a market cap of Rs. 30,000 crores. (10)
Aurobindo Pharma has a foothold in important therapeutic areas such as neurosciences, cardiology, antiretrovirals, anti-diabetics, gastrointestinal, and cephalosporins, amongst others.
When the consolidated revenues of each company in India are considered, Aurobindo Pharma is one of the top 10 pharma companies in India.
More than seventy percent of Aurobindo’s revenue comes from its operations in other countries, which it exports to over 125 nations.
In 2014, Aurobindo paid $41 million to acquire the generic operations Actavis had been running in seven countries across Western Europe.
Lupin Limited is a multinational pharmaceutical corporation with its headquarters in Mumbai. It is among the world’s most successful generic pharmaceutical firms, measured by revenue, and amongst the top 10 pharma companies in India.
Desh Bandhu Gupta, who at the time was a chemistry professor at BITS-Pilani, Rajasthan, was the one who established Lupin in 1968. The market capitalization of the company is Rs. 29,000 crores. (11)
Pediatrics, cardiovascular disease, anti-infectives, diabetology, asthma, and tuberculosis treatment are this company’s primary areas of concentration.
The company’s manufacturing plant was launched to start producing folic acid and iron tablets for the mother and child health program run by the Government of India. Later on, Lupin began producing anti-tuberculosis medications, which, at one point in time, constituted 36% of the business’s revenues and earned the company the reputation of being the biggest TB drug producer in the world.
Lupin’s businesses span the entire pharmaceutical value chain, including branded and generic preparations, active pharmaceutical ingredients (APIs), sophisticated drug delivery systems, and biotechnology.
The pharmaceutical products of the corporation are sold in seventy different countries, and the company’s footprint includes developed markets like the United States of America, Europe, Japan, and Australia. Emerging markets like India, the Philippines, and South Africa are just a few.
India has been contributing a major portion to the global supply of medicines, and it is expected to grow further since the covid pandemic struck. With China plus One sentiment becoming stronger, it is expected that the Indian Pharma industry will become a $ 400 Billion industry in the next 25 years. (12) We can expect more companies to break into the top pharma companies in India list, as the competition is fierce.
Stories about Crypto, Metaverse & Startups.